ENO2 and small cell lung carcinoma: Despite the clinical application of traditional biomarkers such as neuron-specific enolase (NSE) and pro-gastrin-releasing peptide (ProGRP) in SCLC diagnosis, their specificity and sensitivity remain insufficient to meet clinical demands [8,9].